Modifiable Risk Factors for the Spread of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Among Long-Term Acute-Care Hospital Patients

Infection Control and Hospital Epidemiology

Volumn 38, Issue 6, 2017, Pages 670-677

  Okamoto, Koh ^a,e   Lin, Michael Y ^a   Haverkate, Manon ^b   Lolans, Karen ^a   Moore, Nicholas M ^a   Weiner, Shayna ^a   Lyles, Rosie D ^c   Blom, Donald ^a   Rhee, Yoona ^a   Kemble, Sarah ^a   Fogg, Louis ^a   Hines, David W ^d   Weinstein, Robert A ^a,c   Hayden, Mary K ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Cook County Health and Hospitals System ^*  (United States)

^d Metro Infectious Diseases Consultants   (United States)

^e UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CASE CONTROL STUDY; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; EMERGENCY CARE; FECES INCONTINENCE; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; IMMOBILITY; KLEBSIELLA PNEUMONIAE CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RISK FACTOR; STOMACH TUBE; AGED; CLINICAL TRIAL; COMORBIDITY; CROSS INFECTION; ENZYMOLOGY; HEALTH SURVEY; HOSPITAL; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; METABOLISM; MICROBIOLOGY; MULTICENTER STUDY; RECTUM; TRANSMISSION;

AGED; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CASE-CONTROL STUDIES; COMORBIDITY; CROSS INFECTION; FEMALE; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LONG-TERM CARE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RECTUM; RISK FACTORS;

EID: 85020508148     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2017.62     Document Type: Article

References (38)

1. Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase producing Enterobacteriaceae. Emerg Infect Dis 2011;17:1791-1798.
2. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenemresistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53:60-67.
3. Centers for Disease C, Prevention. Vital signs: carbapenemresistant Enterobacteriaceae. Morb Mortal Wkly Rep 2013;62:165-170.
4. Tumbarello M, Trecarichi EM, De Rosa FG, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother 2015;70:2133-2143.
5. Schwaber MJ, Lev B, Israeli A, et al. Containment of a countrywide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848-855.
6. Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013;13:785-796.
7. Marquez P, Terashita D, Dassey D, Mascola L. Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County. Infect Control Hosp Epidemiol 2013;34:144-150.
8. Lin MY, Lyles-Banks RD, Lolans K, et al. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2013;57:1246-1252.
9. Munoz-Price LS. Long-term acute care hospitals. Clin Infect Dis 2009;49:438-443.
10. Gould CV, Rothenberg R, Steinberg JP. Antibiotic resistance in long-term acute care hospitals: the perfect storm. Infect Control Hosp Epidemiol 2006;27:920-925.
11. Hayden MK, Lin MY, Lolans K, et al. Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae in long-term acute-care hospitals. Clin Infect Dis 2015;60:1153-1161.
12. Bonten MJ, Slaughter S, Ambergen AW, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158:1127-1132.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
14. Mangold KA, Santiano K, Broekman R, et al. Real-time detection of blaKPC in clinical samples and surveillance specimens. J Clin Microbiol 2011;49:3338-3339.
15. Lolans K, Calvert K, Won S, Clark J, Hayden MK. Direct ertapenem disk screening method for identification of KPC-producing Klebsiella pneumoniae and Escherichia coli in surveillance swab specimens. J Clin Microbiol 2010;48:836-841.
16. Cole JM, Schuetz AN, Hill CE, Nolte FS. Development and evaluation of a real-time PCR assay for detection of Klebsiella pneumoniae carbapenemase genes. J Clin Microbiol 2009;47:322-326.
17. Prabaker K, Lin MY, McNally M, et al. Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study. Infect Control Hosp Epidemiol 2012;33: 1193-1199.
18. Papadimitriou-Olivgeris M, Marangos M, Fligou F, et al. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis 2013;77:169-173.
19. Bonten MJ. Colonization pressure: a critical parameter in the epidemiology of antibiotic-resistant bacteria. Crit Care 2012;16:142.
20. Schwartz-Neiderman A, Braun T, Fallach N, Schwartz D, Carmeli Y, Schechner V. Risk factors for carbapenemaseproducing carbapenem-resistant enterobacteriaceae (CP-CRE) acquisition among contacts of newly diagnosed CP-CRE patients. Infect Control Hosp Epidemiol 2016:1-7.
21. Ajao AO, Harris AD, Roghmann MC, et al. Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycinresistant enterococci, and Clostridium difficile acquisition. Infect Control Hosp Epidemiol 2011;32:481-489.
22. Swaminathan M, Sharma S, Poliansky Blash S, et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol 2013;34:809-817.
23. Mills JP, Talati NJ, Alby K, Han JH. The epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization and infection among long-term acute care hospital residents. Infect Control Hosp Epidemiol 2016;37:55-60.
24. Papadimitriou-Olivgeris M, Spiliopoulou I, Christofidou M, et al. Co-colonization by multidrug-resistant bacteria in two Greek intensive care units. Eur J Clin Microbiol Infect Dis 2015;34:1947-1955.
25. Tumbarello M, Trecarichi EM, Tumietto F, et al. Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2014;58:3514-3520.
26. Orsi GB, Bencardino A, Vena A, et al. Patient risk factors for outer membrane permeability and KPC-producing carbapenemresistant Klebsiella pneumoniae isolation: results of a double case-control study. Infection 2013;41:61-67.
27. Papadimitriou-Olivgeris M, Marangos M, Fligou F, et al. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother 2012;67:2976-2981.
28. Wu D, Cai J, Liu J. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae. South Med J 2011;104:106-110.
29. Orsi GB, Garcia-Fernandez A, Giordano A, et al. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J Hosp Infect 2011;78:54-58.
30. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 2009;30:666-671.
31. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099-1106.
32. Kwak YG, Choi SH, Choo EJ, et al. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist 2005;11:165-169.
33. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:1028-1033.
34. Prepublication standards-new antimicrobial stewardship standard. The Joint Commission website. https://www.jointcommission.org/standards-information/prepublication-standards.aspx. Published 2016. Accessed November 24, 2016.
35. Bhargava A, Hayakawa K, Silverman E, et al. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities. Infect Control Hosp Epidemiol 2014;35:398-405.
36. Chitnis AS, Caruthers PS, Rao AK, et al. Outbreak of carbapenem-resistant enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions. Infect Control Hosp Epidemiol 2012;33:984-992.
37. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002;136: 834-844.
38. Haverkate MR, Bootsma MC, Weiner S, et al. Modeling spread of KPC-producing bacteria in long-term acute care hospitals in the Chicago region, USA. Infect Control Hosp Epidemiol 2015:1-7.